Atlas Trials

Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease

Clinical trial NCT04232969 · COMPLETED

Trial details

NCT number
NCT04232969
Sponsor
University College, London
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2020-01-20
Primary completion
2024-02-24
Enrollment
194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.